French digital health unicorn Doctolib has its sights set on the Italian market as it looks to build a commercial team this month. The government finally lifted restrictions on telemedicine in December.
The IFC said at HBI 2020 that medical tourism in emerging markets is unlikely to normalise until the end of 2021. Providers say they are already doubling and tripling plans to build in domestic markets, rather than bringing patients to tourism hubs.
Ping An and Teladoc revealed their plans for global expansion at HBI 2020. The former says it's hard to leave such a big domestic market as China but has sights set on SE Asia and 'the developing world'. Teladoc is focused on Europe, Brazil and also on Ping An's home turf, China! Both are now capable of delivering full acuity care and have driven their insights using some of healthcare's largest datasets.
With 125 million people - 80 million of whom live in the big four (Poland, Romania, Czechia and Hungary) - CEE is a large and diverse market. But is it a tempting one? HBI-365 members heard an expert panel in our CEE State of the Regions broadcast suggest that while COVID is creating huge problems across the world, it is also creating opportunities in Central and Eastern Europe.
The world's second-largest economy will start its 14th 5-year plan next year. Panellists at HBI's State of the Region event discussed China's plan to onshore both physical and online healthcare services.
Gilde Healthcare-backed imaging platform RAD-x has entered the German imaging sector with the acquisition of a three-centre group, HBI can reveal, and expects to close more deals in the coming months.
Despite one of the panellists at HBI's DACH-State of the Regions broadcast last week labelling 2020 "the wildest year in recent history in the healthcare sector", there are lots of reasons to feel positive about Europe's German-speaking countries as we look towards the new year.
Soon-to-IPO global renal care group Diaverum has acquired the second-largest private operator of haemodialysis clinics in Malaysia and Singapore, where patients pay upwards of $1,800 a month for treatment in private centres.
India's largest dialysis provider NephroPlus has acquired the fourth-largest private operator in the Philippines, while its home haemodialysis volumes have tripled during the pandemic in India, CEO Vikram Vuppala tells HBI.
Swiss telemedicine player Medgate tells HBI that the end of its joint venture with German hospital group Rhoen Klinikum will allow it to roll out faster in Germany after the Asklepios takeover slowed down the project. HBI also checks in on the partnerships between other big hospitals and their telemedicine partners.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
